dr. kris discusses role of antiangiogenesis in lung cancer
Published 5 years ago • 158 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:14
dr. kris describes the use of genetic testing in lung cancer
-
1:28
dr. kris on the future of immunotherapy and targeted therapy in lung cancer
-
9:12
the current role for antiangiogenic therapy for nsclc
-
1:22
dr. kris on combination chemotherapy approaches in nsclc
-
5:29
mechanisms of anti-angiogenic therapy in lung cancer
-
6:11
how does antiangiogenic therapy work?
-
5:29
resistance to antiangiogenic therapy in lung cancer
-
1:48
dr. mark kris on immunotherapy and frontline options for patients with nsclc
-
1:39
dr. kris on caring for elderly lung cancer patients
-
3:00
nsclc: mechanisms of resistance to antiangiogenic therapy
-
2:20
dr. kris on the relay trial in egfr nsclc
-
3:05
rationale behind antiangiogenic therapy in nsclc
-
0:31
dr. kris discusses available targeted therapies
-
6:01
future directions for antiangiogenic therapy in lung cancer
-
1:01
mark kris, md: antiangiogenic therapy in nsclc
-
4:08
dysregulated angiogenesis in lung cancer
-
2:18
dr. wakelee on first trial to combine antiangiogenesis agents with immunotherapy in nsclc
-
3:11
dysregulated angiogenesis in cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer